Clinical Trial Update: Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing the prevalence and causes of preventable and serious adverse drug reactions from oral anticoagulants, focusing on bleedi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding
• Venous Thromboembolism

Drugs mentioned

• Apixaban (apixaban)
• Dabigatran (Dabigatran etexilate)
• Rivaroxaban (rivaroxaban)
• Warfarin (warfarin)

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Embolism and Thrombosis, Hemorrhage | Phase 4 | Status: COMPLETED